MCH ANALYSIS RESEARCHMain site ↗
Sector

Industrials

167 companies under coverage across 23 industries.

Industries

Browse by industry


Coverage

Industrials companies


Equity Research

Avis Budget Group Inc (CAR)

BUY. 12-month probability-weighted target $157 (+48% vs spot). P/E Multiple explains 46% of Monte Carlo outcome variance.

CAREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +93.3%
Equity Research

Builders FirstSource Inc (BLDR)

BUY. 12-month probability-weighted target $89 (+68% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

BLDREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +58.9%
Equity Research

Ufp Industries Inc (UFPI)

BUY. 12-month probability-weighted target $109 (+47% vs spot). Gross Margin explains 66% of Monte Carlo outcome variance.

UFPIEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +50.0%
Equity Research

Lennox International Inc (LII)

BUY. 12-month probability-weighted target $551 (+55% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

LIIEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +40.2%
Equity Research

Acuity Brands Inc (AYI)

BUY. 12-month probability-weighted target $385 (+29% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

AYIEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +32.7%
Equity Research

Enersys (ENS)

BUY. 12-month probability-weighted target $237 (+32% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

ENSEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +32.1%
Equity Research

Pentair PLC (PNR)

BUY. 12-month probability-weighted target $75 (+43% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

PNREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +31.2%
Equity Research

Dycom Industries Inc (DY)

BUY. 12-month probability-weighted target $403 (+50% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

DYEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +28.3%
Equity Research

MasTec Inc (MTZ)

BUY. 12-month probability-weighted target $330 (+55% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

MTZEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +25.0%
Equity Research

Nextracker Inc. Class A Common Stock (NXT)

HOLD. 12-month probability-weighted target $97 (+13% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

NXTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +21.3%
Equity Research

Carpenter Technology Corporation (CRS)

BUY. 12-month probability-weighted target $554 (+43% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

CRSEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +19.8%
Equity Research

FedEx Freight Holding Company, Inc. (FDXF)

BUY. 12-month probability-weighted target $147 (+28% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

FDXFEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +19.1%
Equity Research

Alaska Air Group Inc (ALK)

HOLD. 12-month probability-weighted target $45 (+15% vs spot). P/E Multiple explains 47% of Monte Carlo outcome variance.

ALKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +18.9%
Equity Research

Copart Inc (CPRT)

HOLD. 12-month probability-weighted target $30 (+8% vs spot). P/E Multiple explains 82% of Monte Carlo outcome variance.

CPRTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +17.1%
Equity Research

Rollins Inc (ROL)

BUY. 12-month probability-weighted target $43 (+35% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

ROLEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +16.7%
Equity Research

Generac Holdings Inc (GNRC)

BUY. 12-month probability-weighted target $266 (+18% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

GNRCEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +15.7%
Equity Research

Watsco Inc (WSO)

BUY. 12-month probability-weighted target $360 (+29% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

WSOEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +15.0%
Equity Research

AAON Inc (AAON)

BUY. 12-month probability-weighted target $128 (+48% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

AAONEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +13.6%
Equity Research

Sterling Infrastructure, Inc. (STRL)

BUY. 12-month probability-weighted target $632 (+23% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

STRLEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +12.1%
Equity Research

SPX Corp (SPXC)

BUY. 12-month probability-weighted target $209 (+23% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

SPXCEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +11.6%
Equity Research

Aecom Technology Corporation (ACM)

BUY. 12-month probability-weighted target $76 (+28% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

ACMEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +11.2%
Equity Research

Cummins Inc (CMI)

BUY. 12-month probability-weighted target $661 (+26% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

CMIEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +11.0%
Equity Research

Dover Corporation (DOV)

HOLD. 12-month probability-weighted target $217 (+15% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

DOVEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +10.8%
Equity Research

Curtiss-Wright Corporation (CW)

BUY. 12-month probability-weighted target $693 (+35% vs spot). P/E Multiple explains 56% of Monte Carlo outcome variance.

CWEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +10.8%
Equity Research

Landstar System Inc (LSTR)

BUY. 12-month probability-weighted target $210 (+24% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

LSTREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +10.7%
Equity Research

American Airlines Group (AAL)

HOLD. 12-month probability-weighted target $15 (+16% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

AALEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +10.7%
Equity Research

United Airlines Holdings Inc (UAL)

BUY. 12-month probability-weighted target $136 (+26% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

UALEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +10.5%
Equity Research

Carrier Global Corp (CARR)

BUY. 12-month probability-weighted target $70 (+25% vs spot). Gross Margin explains 53% of Monte Carlo outcome variance.

CARREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +10.5%
Equity Research

Ryder System Inc (R)

HOLD. 12-month probability-weighted target $268 (+12% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

REquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +9.6%
Equity Research

Parsons Corp (PSN)

BUY. 12-month probability-weighted target $55 (+22% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

PSNEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +9.4%
Equity Research

Regal Beloit Corporation (RRX)

BUY. 12-month probability-weighted target $199 (+21% vs spot). Gross Margin explains 47% of Monte Carlo outcome variance.

RRXEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +9.2%
Equity Research

Saia Inc (SAIA)

BUY. 12-month probability-weighted target $425 (+26% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

SAIAEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +8.8%
Equity Research

Snap-On Inc (SNA)

HOLD. 12-month probability-weighted target $390 (+8% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

SNAEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +8.5%
Equity Research

GXO Logistics Inc (GXO)

HOLD. 12-month probability-weighted target $52 (+12% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

GXOEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +8.1%
Equity Research

Xylem Inc (XYL)

HOLD. 12-month probability-weighted target $112 (+10% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

XYLEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +7.8%
Equity Research

FTI Consulting Inc (FCN)

HOLD. 12-month probability-weighted target $156 (+14% vs spot). Gross Margin explains 70% of Monte Carlo outcome variance.

FCNEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +7.3%
Equity Research

Masco Corporation (MAS)

HOLD. 12-month probability-weighted target $78 (+14% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

MASEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +6.1%
Equity Research

Uber Technologies (UBER)

BUY. 12-month probability-weighted target $83 (+16% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

UBEREquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +5.7%
Equity Research

StandardAero, Inc. (SARO)

BUY. 12-month probability-weighted target $26 (+27% vs spot). Gross Margin explains 62% of Monte Carlo outcome variance.

SAROEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +5.0%
Equity Research

L3Harris Technologies Inc (LHX)

BUY. 12-month probability-weighted target $283 (+19% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

LHXEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +4.8%
Equity Research

Middleby Corp (MIDD)

BUY. 12-month probability-weighted target $129 (+22% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

MIDDEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +4.6%
Equity Research

Terex Corporation (TEX)

BUY. 12-month probability-weighted target $64 (+27% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

TEXEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +4.5%
Equity Research

Simpson Manufacturing Company Inc (SSD)

HOLD. 12-month probability-weighted target $180 (+5% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

SSDEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +4.1%
Equity Research

RB Global Inc. (RBA)

BUY. 12-month probability-weighted target $107 (+25% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

RBAEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +4.1%
Equity Research

CH Robinson Worldwide Inc (CHRW)

BUY. 12-month probability-weighted target $177 (+24% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

CHRWEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +3.9%
Equity Research

TransUnion (TRU)

BUY. 12-month probability-weighted target $76 (+16% vs spot). P/E Multiple explains 64% of Monte Carlo outcome variance.

TRUEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +3.8%
Equity Research

Brinks Company (BCO)

BUY. 12-month probability-weighted target $136 (+31% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BCOEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +3.6%
Equity Research

Smith AO Corporation (AOS)

HOLD. 12-month probability-weighted target $60 (+6% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

AOSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +3.6%
Equity Research

Textron Inc (TXT)

HOLD. 12-month probability-weighted target $81 (+9% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

TXTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +3.4%
Equity Research

Woodward Inc (WWD)

BUY. 12-month probability-weighted target $381 (+14% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

WWDEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +2.7%
Equity Research

BWX Technologies Inc (BWXT)

BUY. 12-month probability-weighted target $168 (+17% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

BWXTEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +2.6%
Equity Research

Southwest Airlines Company (LUV)

BUY. 12-month probability-weighted target $50 (+19% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

LUVEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +2.5%
Equity Research

Advanced Drainage Systems Inc (WMS)

HOLD. 12-month probability-weighted target $142 (+13% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

WMSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +2.1%
Equity Research

Rockwell Automation Inc (ROK)

HOLD. 12-month probability-weighted target $464 (+7% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ROKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +2.1%
Equity Research

Vertiv Holdings Co (VRT)

HOLD. 12-month probability-weighted target $281 (+16% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

VRTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +2.0%
Equity Research

Valmont Industries Inc (VMI)

HOLD. 12-month probability-weighted target $520 (+11% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

VMIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +2.0%
Equity Research

Oshkosh Corporation (OSK)

HOLD. 12-month probability-weighted target $138 (+10% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

OSKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price +1.7%
Equity Research

Honeywell Aerospace Inc (HONA)

BUY. 12-month probability-weighted target $213 (+35% vs spot). Gross Margin explains 68% of Monte Carlo outcome variance.

HONAEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +1.0%
Equity Research

JB Hunt Transport Services Inc (JBHT)

BUY. 12-month probability-weighted target $275 (+20% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

JBHTEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +0.8%
Equity Research

Old Dominion Freight Line Inc (ODFL)

BUY. 12-month probability-weighted target $206 (+13% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

ODFLEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +0.7%
Equity Research

Fortune Brands Innovations Inc. (FBIN)

BUY. 12-month probability-weighted target $50 (+27% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

FBINEquity ResearchMonte Carlo
10 October 2026Rating: BUY · Fair value vs price +0.2%
Equity Research

Mueller Industries Inc (MLI)

HOLD. 12-month probability-weighted target $58 (-5% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

MLIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -0.6%
Equity Research

Fluor Corporation (FLR)

HOLD. 12-month probability-weighted target $48 (-5% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

FLREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -0.7%
Equity Research

Transdigm Group Incorporated (TDG)

HOLD. 12-month probability-weighted target $1273 (+15% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

TDGEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.0%
Equity Research

Moog Inc (MOG-A)

HOLD. 12-month probability-weighted target $390 (+7% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

MOG-AEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.1%
Equity Research

ESAB Corp (ESAB)

HOLD. 12-month probability-weighted target $80 (+20% vs spot). Gross Margin explains 47% of Monte Carlo outcome variance.

ESABEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.1%
Equity Research

GE Vernova LLC (GEV)

HOLD. 12-month probability-weighted target $963 (-4% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

GEVEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.2%
Equity Research

PACCAR Inc (PCAR)

HOLD. 12-month probability-weighted target $118 (+9% vs spot). P/E Multiple explains 48% of Monte Carlo outcome variance.

PCAREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.4%
Equity Research

Timken Company (TKR)

HOLD. 12-month probability-weighted target $130 (+12% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

TKREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -1.7%
Equity Research

Donaldson Company Inc (DCI)

HOLD. 12-month probability-weighted target $90 (+3% vs spot). P/E Multiple explains 49% of Monte Carlo outcome variance.

DCIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -2.3%
Equity Research

Knight Transportation Inc (KNX)

HOLD. 12-month probability-weighted target $75 (+17% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

KNXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -2.8%
Equity Research

Sensata Technologies Holding NV (ST)

HOLD. 12-month probability-weighted target $45 (+5% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

STEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -2.9%
Equity Research

Delta Air Lines Inc (DAL)

HOLD. 12-month probability-weighted target $91 (+10% vs spot). Gross Margin explains 55% of Monte Carlo outcome variance.

DALEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -3.4%
Equity Research

Caterpillar Inc (CAT)

HOLD. 12-month probability-weighted target $993 (+24% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

CATEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -3.6%
Equity Research

Hexcel Corporation (HXL)

HOLD. 12-month probability-weighted target $104 (+22% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

HXLEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -3.9%
Equity Research

Hubbell Inc (HUBB)

HOLD. 12-month probability-weighted target $499 (+5% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

HUBBEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -3.9%
Equity Research

General Dynamics Corporation (GD)

HOLD. 12-month probability-weighted target $337 (+2% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

GDEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -4.3%
Equity Research

GE Aerospace (GE)

HOLD. 12-month probability-weighted target $338 (+10% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

GEEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -4.4%
Equity Research

Owens Corning Inc (OC)

HOLD. 12-month probability-weighted target $138 (+21% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

OCEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -4.5%
Equity Research

Fortive Corp (FTV)

HOLD. 12-month probability-weighted target $58 (+2% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

FTVEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.3%
Equity Research

Equifax Inc (EFX)

HOLD. 12-month probability-weighted target $153 (+5% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

EFXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.8%
Equity Research

Honeywell International Inc (HON)

HOLD. 12-month probability-weighted target $239 (+15% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

HONEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.9%
Equity Research

Comfort Systems USA Inc (FIX)

HOLD. 12-month probability-weighted target $1835 (+7% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

FIXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -5.9%
Equity Research

RTX Corporation (RTX)

HOLD. 12-month probability-weighted target $186 (+0% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

RTXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -6.1%
Equity Research

Ametek Inc (AME)

HOLD. 12-month probability-weighted target $237 (-5% vs spot). P/E Multiple explains 75% of Monte Carlo outcome variance.

AMEEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -6.2%
Equity Research

Core & Main Inc (CNM)

HOLD. 12-month probability-weighted target $44 (+8% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

CNMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -6.6%
Equity Research

Ingersoll Rand Inc (IR)

HOLD. 12-month probability-weighted target $80 (+2% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

IREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -6.9%
Equity Research

United Parcel Service Inc (UPS)

HOLD. 12-month probability-weighted target $104 (+10% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

UPSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -7.0%
Equity Research

EMCOR Group Inc (EME)

HOLD. 12-month probability-weighted target $768 (-3% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

EMEEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -7.3%
Equity Research

XPO Logistics Inc (XPO)

HOLD. 12-month probability-weighted target $210 (+14% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

XPOEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -7.4%
Equity Research

FedEx Corporation (FDX)

HOLD. 12-month probability-weighted target $295 (+1% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

FDXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -7.5%
Equity Research

United Rentals Inc (URI)

HOLD. 12-month probability-weighted target $1122 (+6% vs spot). P/E Multiple explains 67% of Monte Carlo outcome variance.

URIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -7.7%
Equity Research

RBC Bearings Incorporated (RBC)

HOLD. 12-month probability-weighted target $564 (+12% vs spot). P/E Multiple explains 72% of Monte Carlo outcome variance.

RBCEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -8.7%
Equity Research

Otis Worldwide Corp (OTIS)

HOLD. 12-month probability-weighted target $68 (+3% vs spot). Gross Margin explains 56% of Monte Carlo outcome variance.

OTISEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -8.7%
Equity Research

WW Grainger Inc (GWW)

HOLD. 12-month probability-weighted target $1288 (+0% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

GWWEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -8.7%
Equity Research

Dupont De Nemours Inc (DD)

HOLD. 12-month probability-weighted target $133 (+2% vs spot). P/E Multiple explains 53% of Monte Carlo outcome variance.

DDEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.1%
Equity Research

3M Company (MMM)

HOLD. 12-month probability-weighted target $164 (+3% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

MMMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.2%
Equity Research

Illinois Tool Works Inc (ITW)

HOLD. 12-month probability-weighted target $262 (-1% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ITWEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.4%
Equity Research

Allison Transmission Holdings Inc (ALSN)

HOLD. 12-month probability-weighted target $118 (+7% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ALSNEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.5%
Equity Research

Crane Company (CR)

HOLD. 12-month probability-weighted target $214 (+5% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

CREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -9.8%
Equity Research

Graco Inc (GGG)

HOLD. 12-month probability-weighted target $71 (-9% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

GGGEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.3%
Equity Research

Waste Management Inc (WM)

HOLD. 12-month probability-weighted target $220 (+5% vs spot). Gross Margin explains 50% of Monte Carlo outcome variance.

WMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.6%
Equity Research

Lockheed Martin Corporation (LMT)

HOLD. 12-month probability-weighted target $481 (-6% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

LMTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.6%
Equity Research

Carlisle Companies Incorporated (CSL)

HOLD. 12-month probability-weighted target $313 (-2% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

CSLEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.8%
Equity Research

Applied Industrial Technologies (AIT)

HOLD. 12-month probability-weighted target $332 (-1% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

AITEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -10.9%
Equity Research

Kirby Corporation (KEX)

HOLD. 12-month probability-weighted target $140 (+3% vs spot). Gross Margin explains 47% of Monte Carlo outcome variance.

KEXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -11.6%
Equity Research

Howmet Aerospace Inc (HWM)

HOLD. 12-month probability-weighted target $251 (+11% vs spot). P/E Multiple explains 74% of Monte Carlo outcome variance.

HWMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -11.7%
Equity Research

MSC Industrial Direct Company Inc (MSM)

HOLD. 12-month probability-weighted target $123 (-5% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

MSMEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.0%
Equity Research

Veralto Corporation (VLTO)

SELL. 12-month probability-weighted target $85 (-12% vs spot). P/E Multiple explains 63% of Monte Carlo outcome variance.

VLTOEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -12.3%
Equity Research

Northrop Grumman Corporation (NOC)

HOLD. 12-month probability-weighted target $488 (+2% vs spot). Gross Margin explains 61% of Monte Carlo outcome variance.

NOCEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.3%
Equity Research

KBR Inc (KBR)

HOLD. 12-month probability-weighted target $39 (+11% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

KBREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.3%
Equity Research

Huntington Ingalls Industries Inc (HII)

HOLD. 12-month probability-weighted target $269 (+2% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

HIIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.6%
Equity Research

Eaton Corporation PLC (ETN)

HOLD. 12-month probability-weighted target $393 (-8% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

ETNEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -12.7%
Equity Research

UL Solutions Inc. (ULS)

HOLD. 12-month probability-weighted target $69 (-2% vs spot). P/E Multiple explains 54% of Monte Carlo outcome variance.

ULSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.2%
Equity Research

Trane Technologies plc (TT)

HOLD. 12-month probability-weighted target $474 (-1% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

TTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.3%
Equity Research

MSA Safety (MSA)

HOLD. 12-month probability-weighted target $170 (-6% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

MSAEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.8%
Equity Research

Booz Allen Hamilton Holding (BAH)

HOLD. 12-month probability-weighted target $76 (+2% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

BAHEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -13.8%
Equity Research

Flowserve Corporation (FLS)

HOLD. 12-month probability-weighted target $65 (-10% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

FLSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.0%
Equity Research

CNH Industrial N.V. (CNH)

SELL. 12-month probability-weighted target $10 (-10% vs spot). P/E Multiple explains 51% of Monte Carlo outcome variance.

CNHEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -14.0%
Equity Research

Parker-Hannifin Corporation (PH)

HOLD. 12-month probability-weighted target $921 (-4% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

PHEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.1%
Equity Research

Watts Water Technologies Inc (WTS)

HOLD. 12-month probability-weighted target $329 (-7% vs spot). P/E Multiple explains 60% of Monte Carlo outcome variance.

WTSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.2%
Equity Research

Lincoln Electric Holdings Inc (LECO)

HOLD. 12-month probability-weighted target $243 (-7% vs spot). P/E Multiple explains 52% of Monte Carlo outcome variance.

LECOEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.2%
Equity Research

Paylocity Holding Corporation (PCTY)

SELL. 12-month probability-weighted target $128 (-17% vs spot). P/E Multiple explains 76% of Monte Carlo outcome variance.

PCTYEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -14.4%
Equity Research

Leidos Holdings Inc (LDOS)

HOLD. 12-month probability-weighted target $118 (-3% vs spot). Gross Margin explains 63% of Monte Carlo outcome variance.

LDOSEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.4%
Equity Research

IDEX Corporation (IEX)

HOLD. 12-month probability-weighted target $213 (-9% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

IEXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.6%
Equity Research

Verisk Analytics Inc (VRSK)

HOLD. 12-month probability-weighted target $178 (+0% vs spot). P/E Multiple explains 79% of Monte Carlo outcome variance.

VRSKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.7%
Equity Research

AGCO Corporation (AGCO)

HOLD. 12-month probability-weighted target $111 (+7% vs spot). Gross Margin explains 54% of Monte Carlo outcome variance.

AGCOEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.8%
Equity Research

Trex Company Inc (TREX)

HOLD. 12-month probability-weighted target $42 (-7% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

TREXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -14.9%
Equity Research

Allegheny Technologies Incorporated (ATI)

HOLD. 12-month probability-weighted target $181 (-5% vs spot). P/E Multiple explains 55% of Monte Carlo outcome variance.

ATIEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -15.2%
Equity Research

Allegion PLC (ALLE)

SELL. 12-month probability-weighted target $133 (-11% vs spot). P/E Multiple explains 62% of Monte Carlo outcome variance.

ALLEEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -15.4%
Equity Research

AeroVironment Inc (AVAV)

HOLD. 12-month probability-weighted target $142 (+3% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

AVAVEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -15.7%
Equity Research

nVent Electric PLC (NVT)

HOLD. 12-month probability-weighted target $152 (-9% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

NVTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -16.0%
Equity Research

Republic Services Inc (RSG)

HOLD. 12-month probability-weighted target $214 (-1% vs spot). Gross Margin explains 48% of Monte Carlo outcome variance.

RSGEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -16.6%
Equity Research

Tetra Tech Inc (TTEK)

HOLD. 12-month probability-weighted target $31 (-8% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

TTEKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -16.8%
Equity Research

Emerson Electric Company (EMR)

SELL. 12-month probability-weighted target $133 (-18% vs spot). P/E Multiple explains 71% of Monte Carlo outcome variance.

EMREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -17.8%
Equity Research

Stanley Black & Decker Inc (SWK)

HOLD. 12-month probability-weighted target $89 (+1% vs spot). Gross Margin explains 64% of Monte Carlo outcome variance.

SWKEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -18.0%
Equity Research

Axon Enterprise Inc. (AXON)

HOLD. 12-month probability-weighted target $449 (+6% vs spot). P/E Multiple explains 68% of Monte Carlo outcome variance.

AXONEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -18.0%
Equity Research

Exponent Inc (EXPO)

SELL. 12-month probability-weighted target $62 (-11% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

EXPOEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -18.4%
Equity Research

Clean Harbors Inc (CLH)

HOLD. 12-month probability-weighted target $309 (-3% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

CLHEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -18.7%
Equity Research

CSX Corporation (CSX)

HOLD. 12-month probability-weighted target $46 (-3% vs spot). P/E Multiple explains 73% of Monte Carlo outcome variance.

CSXEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -19.0%
Equity Research

Toro Co (TTC)

HOLD. 12-month probability-weighted target $91 (-5% vs spot). Gross Margin explains 52% of Monte Carlo outcome variance.

TTCEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -19.1%
Equity Research

ITT Inc (ITT)

HOLD. 12-month probability-weighted target $187 (-7% vs spot). P/E Multiple explains 59% of Monte Carlo outcome variance.

ITTEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -19.5%
Equity Research

Johnson Controls International PLC (JCI)

SELL. 12-month probability-weighted target $134 (-15% vs spot). P/E Multiple explains 58% of Monte Carlo outcome variance.

JCIEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -19.8%
Equity Research

Union Pacific Corporation (UNP)

HOLD. 12-month probability-weighted target $256 (-8% vs spot). P/E Multiple explains 78% of Monte Carlo outcome variance.

UNPEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -20.1%
Equity Research

Broadridge Financial Solutions Inc (BR)

SELL. 12-month probability-weighted target $135 (-19% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

BREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -20.2%
Equity Research

Jacobs Solutions Inc. (J)

SELL. 12-month probability-weighted target $123 (-12% vs spot). Gross Margin explains 60% of Monte Carlo outcome variance.

JEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -21.1%
Equity Research

Nordson Corporation (NDSN)

SELL. 12-month probability-weighted target $275 (-16% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

NDSNEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -21.8%
Equity Research

Fastenal Company (FAST)

SELL. 12-month probability-weighted target $43 (-15% vs spot). P/E Multiple explains 65% of Monte Carlo outcome variance.

FASTEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -22.3%
Equity Research

Deere & Company (DE)

HOLD. 12-month probability-weighted target $579 (-7% vs spot). Gross Margin explains 44% of Monte Carlo outcome variance.

DEEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -22.6%
Equity Research

Quanta Services Inc (PWR)

HOLD. 12-month probability-weighted target $656 (-7% vs spot). Gross Margin explains 59% of Monte Carlo outcome variance.

PWREquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -22.9%
Equity Research

WESCO International Inc (WCC)

SELL. 12-month probability-weighted target $316 (-14% vs spot). Gross Margin explains 58% of Monte Carlo outcome variance.

WCCEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.1%
Equity Research

Westinghouse Air Brake Technologies Corp (WAB)

SELL. 12-month probability-weighted target $252 (-12% vs spot). P/E Multiple explains 61% of Monte Carlo outcome variance.

WABEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.1%
Equity Research

Automatic Data Processing Inc (ADP)

SELL. 12-month probability-weighted target $219 (-19% vs spot). P/E Multiple explains 69% of Monte Carlo outcome variance.

ADPEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -23.1%
Equity Research

Norfolk Southern Corporation (NSC)

HOLD. 12-month probability-weighted target $306 (-4% vs spot). P/E Multiple explains 70% of Monte Carlo outcome variance.

NSCEquity ResearchMonte Carlo
10 October 2026Rating: HOLD · Fair value vs price -23.2%
Equity Research

Expeditors International of Washington, Inc. (EXPD)

SELL. 12-month probability-weighted target $156 (-19% vs spot). Gross Margin explains 57% of Monte Carlo outcome variance.

EXPDEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -24.7%
Equity Research

ExlService Holdings Inc (EXLS)

SELL. 12-month probability-weighted target $27 (-26% vs spot). P/E Multiple explains 57% of Monte Carlo outcome variance.

EXLSEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -25.0%
Equity Research

Cintas Corporation (CTAS)

SELL. 12-month probability-weighted target $170 (-16% vs spot). P/E Multiple explains 66% of Monte Carlo outcome variance.

CTASEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -27.4%
Equity Research

Science Applications International Corporation Common Stock (SAIC)

SELL. 12-month probability-weighted target $117 (-13% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

SAICEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -29.4%
Equity Research

Kratos Defense & Security Solutions (KTOS)

SELL. 12-month probability-weighted target $34 (-19% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

KTOSEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -33.6%
Equity Research

CACI International Inc (CACI)

SELL. 12-month probability-weighted target $497 (-19% vs spot). Gross Margin explains 69% of Monte Carlo outcome variance.

CACIEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -36.9%
Equity Research

Vicor Corporation (VICR)

SELL. 12-month probability-weighted target $192 (-28% vs spot). P/E Multiple explains 84% of Monte Carlo outcome variance.

VICREquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -42.3%
Equity Research

Louisiana-Pacific Corporation (LPX)

SELL. 12-month probability-weighted target $36 (-45% vs spot). Gross Margin explains 65% of Monte Carlo outcome variance.

LPXEquity ResearchMonte Carlo
10 October 2026Rating: SELL · Fair value vs price -54.1%
Equity Research

Maximus Inc (MMS)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

MMSEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Genpact Limited (G)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

GEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

Api Group Corp (APG)

Rating suspended since 2026-09-21 — valuation input under review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

APGEquity ResearchMonte Carlo
10 October 2026Rating: N/A
Equity Research

GATX Corporation (GATX)

Rating suspended since 2026-10-01 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

GATXEquity ResearchMonte Carlo
1 October 2026Rating: N/A
Equity Research

Paychex Inc (PAYX)

Rating suspended since 2026-09-29 — under analyst review. The rating, price target and expected return are withheld until the name is re-valued; the research on the report page predates the review.

PAYXEquity ResearchMonte Carlo
30 September 2026Rating: N/A
MCH ANALYSIS · All research · Research, not personal financial advicemchadvisoryservices.com ↗ · Research Standard v4 (decision-level) · Research OS ros-1.20.0 · US-listed

MCH Analysis is a general investment-research publication of MCH Advisory (Pty) Ltd. It is not personal financial advice and does not take your circumstances into account. MCH is not a licensed financial services provider or a registered investment adviser. Past performance, whether actual or simulated, does not predict future results. Subscriber Agreement | Privacy and Cookie Notice | Research Governance Policies